{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:17:55Z","timestamp":1792811875715,"version":"4.5.0"},"reference-count":203,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.preteyeres.2005.01.004","type":"journal-article","created":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T10:28:51Z","timestamp":1112610531000},"page":"587-611","source":"Crossref","is-referenced-by-count":124,"title":["Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Jost B.","family":"Jonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kreissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Degenring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2005.01.004_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajo.2004.05.031","article-title":"Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide","volume":"138","author":"Agrawal","year":"2004","journal-title":"Am. J. Ophthalmol."},{"issue":"5, Suppl.","key":"10.1016\/j.preteyeres.2005.01.004_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00006982-200410001-00002","article-title":"Evolving guidelines for intravitreous injections","volume":"24","author":"Aiello","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ajo.2004.01.032","article-title":"Intravitreal triamcinolone acetonide for the management of diabetic papillopathy","volume":"137","author":"Al-Haddad","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00006982-200302000-00022","article-title":"Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis","volume":"23","author":"Alldredge","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajo.2003.08.035","article-title":"Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt\u2013Koyanagi\u2013Harada syndrome","volume":"137","author":"Andrade","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF01681698","article-title":"The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularisation","volume":"231","author":"Antoszyk","year":"1993","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib8","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1167\/iovs.03-1110","article-title":"Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema","volume":"45","author":"Audren","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3928\/1542-8877-20030901-08","article-title":"The effect of intravitreal triamcinolone acetonide on intraocular pressure","volume":"34","author":"Bakri","year":"2003","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib10","article-title":"Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema","author":"Bakri","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-004-0911-1","article-title":"Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy","author":"Bandello","year":"2004","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archopht.122.8.1137","article-title":"Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion","volume":"122","author":"Bashshur","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.1966.03850010479003","article-title":"Intraocular pressure and its response to topical corticosteroids in diabetes","volume":"76","author":"Becker","year":"1966","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","article-title":"Intravitreal triamcinolone for refractory pseudophakic macular edema","volume":"135","author":"Benhamou","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib16","first-page":"661","article-title":"[Intravitreal injection of triamcinolone acetonide in non infectious uveitis]","volume":"76","author":"Benitez Del Castillo Sanchez","year":"2001","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archopht.121.2.271","article-title":"Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone","volume":"121","author":"Benz","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archopht.1984.01040030470029","article-title":"Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation","volume":"102","author":"Blumenkranz","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0161-6420(83)34388-8","article-title":"Diabetic retinopathy: a critical review highlighting diffuse macular edema","volume":"90","author":"Bresnick","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0039-6257(88)90052-5","article-title":"Age-related macular degeneration","volume":"32","author":"Bressler","year":"1988","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib22","first-page":"1048","article-title":"Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis","volume":"25","author":"Bui Quoc","year":"2002","journal-title":"J. Fr. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0886-3350(03)00016-6","article-title":"Visualizing vitreous using Kenalog suspension","volume":"29","author":"Burk","year":"2003","journal-title":"J. Cataract. Refract. Surg."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-9394(02)02030-5","article-title":"Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults","volume":"135","author":"Bynoe","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1524-4725.2002.02012.x","article-title":"Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts","volume":"28","author":"Carroll","year":"2002","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1442-9071.1998.tb01330.x","article-title":"Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up","volume":"26","author":"Challa","year":"1998","journal-title":"Aust. NZ. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib27","article-title":"Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study","author":"Chan","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02150144","article-title":"Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment","volume":"225","author":"Chandler","year":"1987","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib29","first-page":"2160","article-title":"The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy","volume":"33","author":"Chen","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.88.1.154","article-title":"Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion","volume":"88","author":"Chen","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/bjo.2003.033589","article-title":"Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema","volume":"88","author":"Chen","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bjo.2004.041707","article-title":"Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study","volume":"88","author":"Ciardella","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archopht.119.3.399","article-title":"Intravitreal triamcinolone acetonide inhibits choroidal neovascularisation in a laser-treated rat model","volume":"119","author":"Ciulla","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/bjo.87.8.1032","article-title":"Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants","volume":"87","author":"Ciulla","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib205","first-page":"890","article-title":"Treatment of pseudophakic cystoid macular edema by elevation of intraocular pressure","volume":"16","author":"Civerchia","year":"1984","journal-title":"Ann. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00006982-199212010-00010","article-title":"Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis","volume":"12","author":"Coats","year":"1992","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0161-6420(03)00242-2","article-title":"SubTenon's infusion of steroids for treatment of orbital hemangiomas","volume":"110","author":"Coats","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","article-title":"Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema","volume":"29","author":"Conway","year":"2003","journal-title":"J. Cataract. Refract. Surg."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib38","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0161-6420(96)30383-7","article-title":"Inhibition of preretinal and optic nerve head neovascularisation in pigs by intravitreal triamcinolone acetonide","volume":"103","author":"Danis","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","article-title":"Intravitreal triamcinolone acetonide in exudative age-related macular degeneration","volume":"20","author":"Danis","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/bjo.87.3.361","article-title":"Intravitreal injection of triamcinolone acetonide as treatment of chronic uveitis","volume":"87","author":"Degenring","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib41","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ajo.2004.01.008","article-title":"Serum levels of triamcinolone acetonide after intravitreal injection","volume":"137","author":"Degenring","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib42","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archopht.122.10.1571-b","article-title":"Rinsing of the cannula prior to intravitreal injection","volume":"122","author":"Degenring","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1034\/j.1600-0420.2003.00084.x","article-title":"Morphologic and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion","volume":"81","author":"Degenring","year":"2003","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib44","first-page":"48","article-title":"Macular grid laser coagulation for diffuse diabetic macular edema","volume":"221","author":"Degenring","year":"2004","journal-title":"Klin. Monatsbl. Augenheilkd."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s00347-003-0862-7","article-title":"Intraokul\u00e4re medikament\u00f6se Therapie des diffusen diabetischen Makula\u00f6dems","author":"Degenring","year":"2004","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib46","first-page":"45","article-title":"Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide","volume":"292","author":"Detry-Morel","year":"2004","journal-title":"Bull. Soc. Belge Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib47","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1","volume":"103","year":"1985","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0161-6420(13)38011-7","article-title":"Early photocoagulation for diabetic retinopathy. ETDRS report number 9","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib49","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00006982-200312000-00003","article-title":"Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases","volume":"23","author":"Enaida","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(02)01917-7","article-title":"Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy","volume":"135","author":"Enaida","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00000658-198709000-00016","article-title":"Angiostatic steroids. Method of discovery and mechanism of action","volume":"206","author":"Folkman","year":"1987","journal-title":"Ann. Surg."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00006982-200312000-00004","article-title":"Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy","volume":"23","author":"Furino","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.visres.2003.09.027","article-title":"Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina","volume":"44","author":"Gao","year":"2004","journal-title":"Vision Res."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib54","article-title":"Intravitreal triamcinolone for macular detachment following panretinal photocoagulation","author":"Gharbiya","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00006982-199515040-00005","article-title":"Vitrectomy for accidental intraocular steroid injection","volume":"15","author":"Ghopal","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib56","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","article-title":"A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results","volume":"121","author":"Gillies","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archopht.122.3.336","article-title":"Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial","volume":"122","author":"Gillies","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archopht.1974.01010010155016","article-title":"Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis","volume":"92","author":"Graham","year":"1974","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.86.2.247","article-title":"Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion","volume":"86","author":"Greenberg","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib60","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0161-6420(02)01743-8","article-title":"Proptosis after retrobulbar corticosteroid injections","volume":"110","author":"Gupta","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib61","article-title":"Severe sub conjunctival haemorrhage following intravitreal triamcinolone for refractory diabetic oedema","author":"Gupta","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib62","unstructured":"Haddad, W.M., Souied, E., Coscas, G., Soubrane, G., 2004. Treatment of exudative AMD with chorioretinal anastomosis: a comparative study of photodynamic therapy with and without intravitreal injection of triamcinolone acetonide ARVO-Abstracts 3163\/B 798."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000068980","article-title":"Management of central retinal vein occlusion","volume":"217","author":"Hayreh","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00920049","article-title":"Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study","volume":"228","author":"Hayreh","year":"1990","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib67","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","article-title":"Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations","volume":"101","author":"Hida","year":"1986","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib68","first-page":"92","article-title":"[Intravitreal injection of triamcinolone acetonide for cystoid macular edema resistant to vitreous surgery]","volume":"108","author":"Inoue","year":"2004","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib69","first-page":"1217","article-title":"Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion","volume":"120","author":"Ip","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/soph.18.2.67.15860","article-title":"Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study","volume":"18","author":"Ip","year":"2003","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib71","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archopht.122.8.1131","article-title":"Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion","volume":"122","author":"Ip","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib72","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archopht.1985.01050050100026","article-title":"Effects of intravitreal administration of steroids on experimental subretinal neovascularisation in the subhuman primate","volume":"103","author":"Ishibashi","year":"1985","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00347-003-0975-z","article-title":"Nebenwirkungen und Komplikationen der intravitrealen Triamcinolonacetonid-Therapie","volume":"101","author":"Jaissle","year":"2004","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib74","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.86.12.1450-a","article-title":"Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil","volume":"86","author":"Jonas","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib75","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/bjo.86.9.1066","article-title":"Concentration of intravitreally applicated triamcinolone acetonide in aqueous humour","volume":"86","author":"Jonas","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib76","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00417-003-0719-4","article-title":"Intravitreal triamcinolone acetonide as treatment of chronic focal immunologic corneal graft reaction","volume":"241","author":"Jonas","year":"2003","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib77","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ajo.2003.08.012","article-title":"Intraocular availability of triamcinolone acetonide after intravitreal injection","volume":"137","author":"Jonas","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0002-9394(03)00899-7","article-title":"Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia","volume":"137","author":"Jonas","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjo.2003.028688","article-title":"Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment?","volume":"88","author":"Jonas","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib82","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bjo.2003.034140","article-title":"Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide","volume":"88","author":"Jonas","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib83","doi-asserted-by":"crossref","DOI":"10.1136\/bjo.2004.054247","article-title":"Intravitreal triamcinolone acetonide and central serous retinochoroidopathy","author":"Jonas","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","article-title":"Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema","volume":"132","author":"Jonas","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib81","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/S0886-3350(02)01295-6","article-title":"Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularisation","volume":"28","author":"Jonas","year":"2002","journal-title":"J. Cataract. Refract. Surg."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib84","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy","volume":"84","author":"Jonas","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib85","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00061198-200108000-00007","article-title":"Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone","volume":"10","author":"Jonas","year":"2001","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib86","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s004170100293","article-title":"Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony","volume":"239","author":"Jonas","year":"2001","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib87","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9394(00)00882-5","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy","volume":"131","author":"Jonas","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib88","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00417-002-0529-0","article-title":"Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion","volume":"240","author":"Jonas","year":"2002","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib89","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00417-002-0547-y","article-title":"Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration","volume":"240","author":"Jonas","year":"2002","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib90","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/bjo.87.4.462","article-title":"Intravitreal triamcinolone acetonide for exudative age-related macular degeneration","volume":"87","author":"Jonas","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone acetonide for diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib92","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1034\/j.1600-0420.2003.00130.x","article-title":"Neovascular glaucoma treated by intravitreal triamcinolone acetonide","volume":"81","author":"Jonas","year":"2003","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib93","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib94","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/112067210301300508","article-title":"Intravitreal triamcinolone acetonide as additional tool in pars plana vitrectomy for proliferate diabetic retinopathy","volume":"13","author":"Jonas","year":"2003","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib95","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bjo.87.1.24","article-title":"Intraocular pressure after intravitreal injection of triamcinolone acetonide","volume":"87","author":"Jonas","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib96","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archopht.121.5.729","article-title":"Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib97","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/archopht.121.11.1663-b","article-title":"Endophthalmitis after intravitreal injection of triamcinolone acetonide","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib98","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/112067210301300611","article-title":"Intravitreal triamcinolone as treatment for ischemic ophthalmopathy","volume":"13","author":"Jonas","year":"2003","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib99","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1395-3907.2003.0108.x","article-title":"Intravitreal crystalline triamcinolone acetonide as additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?","volume":"81","author":"Jonas","year":"2003","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archopht.122.2.218","article-title":"Intravitreal re-injection of triamcinolone for exudative age-related macular degeneration","volume":"122","author":"Jonas","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib101","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2004.02.025","article-title":"Duration of the effect of intravitreal triamcinolone acetonide as treatment of diffuse diabetic macular edema","volume":"138","author":"Jonas","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib102","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00417-003-0841-3","article-title":"Retinal complications of intravitreal injections of triamcinolone acetonide","volume":"242","author":"Jonas","year":"2004","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib103","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00061198-200406000-00016","article-title":"Filtering surgery after intravitreal triamcinolone acetonide injection","volume":"13","author":"Jonas","year":"2004","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib104","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/bjo.2003.039552","article-title":"Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age-related macular degeneration","volume":"88","author":"Jonas","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.eye.6700654","article-title":"Cataract surgery after intravitreal injection of triamcinolone acetonide","volume":"18","author":"Jonas","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib106","article-title":"Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative non-randomized study","author":"Jonas","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib107","article-title":"Intravitreal triamcinolone acetonide as treatment of branch retinal vein occlusion","author":"Jonas","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2004.07.007","article-title":"Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide","author":"Jonas","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib109","doi-asserted-by":"crossref","unstructured":"Jonas, J.B., Kreissig, I., Degenring, R.F., Kamppeter, B., 2005a. Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema. Br. J. Ophthalmol., forthcoming.","DOI":"10.1136\/bjo.2004.050575"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib110","article-title":"Safety of intravitreal high-dose re-injections of triamcinolone acetonide","author":"Jonas","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib111","doi-asserted-by":"crossref","DOI":"10.1136\/bjo.2004.046391","article-title":"Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide. A comparative non-randomised study","author":"Jonas","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib113","doi-asserted-by":"crossref","DOI":"10.1001\/archopht.123.10.1338","article-title":"Predictive factors for visual acuity change after intravitreal triamcinolone for diabetic macular edema","author":"Jonas","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib114","article-title":"Cataract surgery combined with intravitreal injection of triamcinolone acetonide","author":"Jonas","year":"2005","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib115","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1395-3907.2003.0146.x","article-title":"Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema","volume":"81","author":"Karacorlu","year":"2003","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib116","article-title":"Intravitreal triamcinolone as a primary therapy in diabetic macular oedema","author":"Karacorlu","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib117","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/B:INTE.0000031740.85124.78","article-title":"Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone","volume":"25","author":"Karacorlu","year":"2004","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib118","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00006982-200404000-00030","article-title":"Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young patients","volume":"24","author":"Karacorlu","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib119","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2004.02.053","article-title":"Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behcet disease","volume":"138","author":"Karacorlu","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib120","first-page":"758","article-title":"Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion","volume":"137","author":"Kaushik","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib121","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0002-9394(03)00782-7","article-title":"Triamcinolone acetonide-assisted peeling of the internal limiting membrane","volume":"137","author":"Kimura","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib122","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00006982-200406000-00022","article-title":"Intravitreal triamcinolone acetonide injection in ocular ischemic syndrome","volume":"24","author":"Klais","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib123","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajo.2004.04.064","article-title":"Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease","volume":"138","author":"Kramer","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib124","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/bjo.2004.043406","article-title":"Sequential treatment of central retinal vein occlusion with intravitreal tissue plasminogen activator and intravitreal triamcinolone","volume":"88","author":"Lahey","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib125","article-title":"Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study","author":"Lam","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib126","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0161-6420(91)32082-7","article-title":"Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results","volume":"98","author":"Lee","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib127","first-page":"692","article-title":"Intravitreal triamcinolone injection for macular edema secondary to increased retinal vascular permeability","volume":"103","author":"Lee","year":"2004","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib128","first-page":"1771","article-title":"Proliferative vitreoretinopathy, PVR: a personal account of its pathogenesis and treatment. Proctor lecture","volume":"29","author":"Machemer","year":"1988","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00006982-199616020-00017","article-title":"Five cases in which a depot steroid, hydrocortisone acetate and methylprednisolone acetate was injected into the eye","volume":"16","author":"Machemer","year":"1996","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib130","first-page":"171","article-title":"Treatment of intraocular proliferations with intravitreal steroids","volume":"77","author":"Machemer","year":"1979","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib131","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/jm010511b","article-title":"Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of a novel mitomycin C-triamcinolone acetonide conjugate","volume":"45","author":"Macky","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib132","first-page":"1380","article-title":"Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy","volume":"119","author":"Martidis","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib133","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib134","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/archopht.121.11.1658","article-title":"Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis","volume":"121","author":"Martinez","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib136","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00006982-200308000-00028","article-title":"Retinal detachment in morning glory syndrome treated by triamcinolone acetonide-assisted pars plana vitrectomy","volume":"23","author":"Matsumoto","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib137","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9394(81)90013-1","article-title":"The lack of toxicity of intravitreally administered triamcinolone acetonide","volume":"91","author":"McCuen","year":"1981","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib138","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00006982-198500520-00001","article-title":"Grid photocoagulation for diffuse macular edema","volume":"5","author":"McDonald","year":"1985","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib206","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0161-6420(93)31675-1","article-title":"Corticosteroid-induced ocular hypertension in the treatment of aphakic or pseudophakic cystoid macular edema","volume":"100","author":"Melberg","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib139","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/112067210401400407","article-title":"Intravitreal triamcinolone acetonide: valuation of retinal thickness changes measured by optical coherence tomography in diffuse diabetic macular edema","volume":"14","author":"Micelli Ferrari","year":"2004","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib140","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0161-6420(95)30846-9","article-title":"Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study","volume":"102","author":"Mitchell","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib141","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3928\/1542-8877-19981101-12","article-title":"Accidental subretinal injection of triamcinolone acetonide","volume":"29","author":"Modarres","year":"1998","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib142","article-title":"Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits","author":"Morrison","year":"2004","journal-title":"ARVO"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib143","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0002-9394(02)01426-5","article-title":"Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection","volume":"134","author":"Moshfeghi","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib144","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":"Acute endophthalmitis following intravitreal triamcinolone acetonide injection","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajo.2004.03.025","article-title":"Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema","volume":"138","author":"Moshfeghi","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib146","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.eye.6700457","article-title":"Indocyanine green-mediated photothrombosis combined with intravitreal triamcinolone for the treatment of choroidal neovascularisation in serpiginous choroiditis","volume":"17","author":"Navajas","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib147","article-title":"Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation","author":"Negi","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib148","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00006982-200310000-00014","article-title":"Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection","volume":"23","author":"Nelson","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib149","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00006982-200312000-00005","article-title":"Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter","volume":"23","author":"Nishimura","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib150","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/bjo.87.8.968","article-title":"Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis","volume":"87","author":"Okada","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib151","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0161-6420(86)33638-8","article-title":"Modified grid argon, blue-green laser photocoagulation for diffuse diabetic macular edema","volume":"93","author":"Olk","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib152","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archopht.119.6.897","article-title":"Risk factors for glaucoma progression: where does intraocular pressure fit in?","volume":"119","author":"Palmberg","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib153","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib154","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ajo.2003.08.051","article-title":"Intravitreal triamcinolone and endophthalmitis","volume":"136","author":"Parke","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib155","article-title":"Intravitreal triamcinolone acetonide in Eales\u2019 disease: a case report","author":"Pathengay","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib156","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bjo.86.5.527","article-title":"Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration","volume":"86","author":"Penfold","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib157","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo.86.6.600","article-title":"Intravitreal triamcinolone in recurrence of choroidal neovascularisation","volume":"86","author":"Penfold","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib158","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1442-9071.1995.tb00179.x","article-title":"Exudative macular degeneration and intravitreal triamcinolone. A pilot study","volume":"23","author":"Penfold","year":"1995","journal-title":"Aust. NZ. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib159","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.2000.01316.x","article-title":"Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1, ICAM-1, expression of the ECV304 cell line: complications for macular degeneration","volume":"121","author":"Penfold","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1442-9071.2001.00407.x","article-title":"Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration","volume":"29","author":"Penfold","year":"2001","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib161","first-page":"3125","article-title":"Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells","volume":"43","author":"Penfold","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib162","first-page":"283","article-title":"The effect of an angiostatic steroid on neovascularisation in a rat model of retinopathy of prematurity","volume":"42","author":"Penn","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib164","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006982-200005000-00024","article-title":"Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy","volume":"20","author":"Peyman","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib165","first-page":"43","article-title":"[Treatment of Graves macular edema with intravitreal injection of corticosteroids]","volume":"288","author":"Rakic","year":"2003","journal-title":"Bull. Soc. Belge Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib166","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bjo.86.5.527","article-title":"Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration","volume":"86","author":"Ranson","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib167","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(03)00389-1","article-title":"Intravitreal triamcinolone for choroidal neovascularisation in ocular histoplasmosis syndrome","volume":"136","author":"Rechtman","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib168","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.2003.027177","article-title":"Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration","volume":"88","author":"Rechtman","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib169","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1432-2277.2002.tb00134.x","article-title":"Adjunctive intracameral application of corticosteroids in patients with endothelial immune reactions after penetrating keratoplasty. A pilot study. Transplant International. I","volume":"15","author":"Reinhard","year":"2002","journal-title":"Transplant Int."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/112067210301300309","article-title":"Intraocular steroids as a treatment for blind painful red eyes","volume":"13","author":"Rodriguez","year":"2003","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib171","doi-asserted-by":"crossref","unstructured":"Rodriguez-Coleman, H., Yuan, P., Kim, H., Gravlin, L., Srivastava, S., Csaky, K.G., Robinson, M.R., 2004. Intravitreal injection of triamcinolone for diffuse diabetic macular edema, Letter-to-the-Editor, concerning the article Jonas JB, Kreissig I, S\u00f6fker A, Degenring RF. Intravitreal injection of triamcinolone acetonide for diabetic macular edema. Arch. Ophthalmol. 2003;121:57\u201361. Arch. Ophthalmol. (forthcoming).","DOI":"10.1001\/archopht.121.1.57"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib172","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archopht.121.9.1279","article-title":"Noninfectious endophthalmitis associated with intravitreal triamcinolone injection","volume":"121","author":"Roth","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib173","article-title":"Intravitreal triamcinolone combined with photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration","author":"Roth","year":"2004","journal-title":"ARVO"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib174","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00417-002-0454-2","article-title":"Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown","volume":"240","author":"Sakamoto","year":"2002","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4615-0067-4_10","article-title":"Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide: case report","volume":"533","author":"Sallum","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib176","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3928\/1542-8877-20030901-11","article-title":"Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide","volume":"34","author":"Saraiva","year":"2003","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib177","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(82)90130-1","article-title":"The clearance of intravitreal triamcinolone acetonide","volume":"93","author":"Schindler","year":"1982","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib178","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archopht.1985.01050100143037","article-title":"Clearance of triamcinolone from vitreous","volume":"103","author":"Scholes","year":"1985","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib179","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9394(03)00266-6","article-title":"Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema","volume":"136","author":"Scott","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib180","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajo.2004.03.001","article-title":"Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection","volume":"138","author":"Singh","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib181","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ajo.2004.05.073","article-title":"Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis","volume":"138","author":"Smithen","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib182","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib183","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bjo.87.8.1010","article-title":"Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study","volume":"87","author":"Sonoda","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib184","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","article-title":"Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularisation","volume":"110","author":"Spaide","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib185","doi-asserted-by":"crossref","DOI":"10.1136\/bjo.2004.052563","article-title":"Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo","author":"Spandau","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2004.09.059","article-title":"Measurement of triamcinolone acetonide concentration after filtering of solvent agent","author":"Spandau","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib187","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archopht.121.10.1491","article-title":"Intravitreal triamcinolone for radiation-induced macular edema","volume":"121","author":"Sutter","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib188","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/bjo.87.8.972","article-title":"Pseudo-endophthalmitis after intravitreal injection of triamcinolone","volume":"87","author":"Sutter","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib189","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib190","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0002-9394(03)00674-3","article-title":"Residual triamcinolone acetonide in the macular hole after vitrectomy","volume":"136","author":"Takeuchi","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib191","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0002-9394(14)75196-7","article-title":"Treatment of intraocular proliferation with intravitreal injection of tramcinolone acetonide","volume":"90","author":"Tano","year":"1980","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib192","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0002-9394(80)90239-1","article-title":"Inhibition of intraocular proliferation with intravitreal corticosteroid","volume":"89","author":"Tano","year":"1980","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib193","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-6420(95)31034-2","article-title":"The prevalence of age-related maculopathy in the Rotterdam Study","volume":"102","author":"Vingerling","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib196","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00417-001-0398-y","article-title":"Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells","volume":"240","author":"Wang","year":"2002","journal-title":"Graef. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib197","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archopht.1992.01080200135041","article-title":"Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation","volume":"110","author":"Wilson","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib198","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1440-1606.1999.00238.x","article-title":"Intravitreal triamcinolone and elevated intraocular pressure","volume":"27","author":"Wingate","year":"1999","journal-title":"Aust. NZ. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib199","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajo.2004.05.033","article-title":"Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery","volume":"138","author":"Yamakiri","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib200","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000078615","article-title":"Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole","volume":"218","author":"Yamamoto","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib201","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000079470","article-title":"Double visualization using triamcinolone acetonide and trypan blue during stage 3 macular hole surgery","volume":"218","author":"Yamamoto","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2005.01.004_bib202","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1167\/iovs.03-0490","article-title":"The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone","volume":"44","author":"Yeung","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib203","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10384-003-0053-8","article-title":"Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone","volume":"48","author":"Yeung","year":"2004","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2005.01.004_bib204","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","article-title":"Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis","volume":"29","author":"Young","year":"2001","journal-title":"Clin. Exp. Ophthalmol."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946205000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946205000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T20:52:59Z","timestamp":1625691179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946205000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":203,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1350946205000145"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2005.01.004","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}